Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

ExPERT Platform - aVenture Products & Services Research

ExPERT Platform

EP

ExPERT Platform

ProductOperating Status: Currently Offered

MaxCyte's ExPERT platform uses non-viral electroporation to transfect cells for research, clinical, and commercial cell-engineering workflows.

Loading

The ExPERT platform is MaxCyte's family of electroporation instruments, scaling from a 96-well discovery format up to flow-electroporation systems that transfect up to 20 billion cells. It uses non-viral static or flow electroporation to deliver nucleic acids and gene-editing components across many cell types.

MaxCyte sells the platform with matching processing assemblies, buffers, and reagents for cell therapy, gene editing, protein and antibody production, viral-vector production, and vaccine development. It serves cell and gene therapy developers moving from research through cGMP-compliant clinical manufacturing.

ExPERT Platform - Direct Competitors

Navan Technologies
NanoStraw
navanbio.com

ExPERT Platform - Similar Products & Services

Gene Pulser Xcell Electroporation Systems Bio-Rad
Gene Pulser Xcell Electroporation Systems are modular electroporation instruments for transfecting primary, stem, and difficult-to-transfect cells.
Neon NxT Electroporation System Thermo Fisher Scientific
Neon NxT Electroporation System is a benchtop electroporation instrument for delivering nucleic acids and proteins into difficult-to-transfect mammalian cells.
Flowfect Tx Platform Kytopen
The Flowfect Tx Platform is Kytopen's closed-system instrument for large-scale, continuous-flow transfection of cells.

Gene Pulser Xcell Electroporation Systems
Gene Pulser Xcell Electroporation Systems are modular electroporation instruments for transfecting primary, stem, and difficult-to-transfect cells.
Offered byBio-Rad
Neon NxT Electroporation System
Neon NxT Electroporation System is a benchtop electroporation instrument for delivering nucleic acids and proteins into difficult-to-transfect mammalian cells.

Thermo Fisher Scientific

Flowfect Tx Platform

The Flowfect Tx Platform is Kytopen's closed-system instrument for large-scale, continuous-flow transfection of cells.